Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Checkpoint Therapeutics Inc (CKPT)

Checkpoint Therapeutics Inc (CKPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Checkpoint Therapeutics Inc 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 USA

www.checkpointtx.com Employees: 23 P: 781-652-4500

Description:

Checkpoint Therapeutics, Inc. is a clinical stage, immuno oncology biopharmaceutical. It focused on the acquisition, development and commercialization of non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Checkpoint Therapeutics, Inc. is headquartered in New York City.

Key Statistics

Overview:

Market Capitalization, $K 164,567
Enterprise Value, $K 159,637
Shares Outstanding, K 48,833
Annual Sales, $ 100 K
Annual Net Income, $ -51,850 K
Last Quarter Sales, $ 40 K
Last Quarter Net Income, $ -6,670 K
EBIT, $ -35,490 K
EBITDA, $ -35,490 K
60-Month Beta 1.34
% of Insider Shareholders 2.10%
% of Institutional Shareholders 22.00%
Float, K 47,808
% Float 97.90%
Short Volume Ratio 0.65

Growth:

1-Year Return 113.07%
3-Year Return -87.98%
5-Year Return -76.71%
5-Year Revenue Growth -97.15%
5-Year Earnings Growth 75.04%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.23 on 11/12/24
Next Earnings Date 11/11/24
Earnings Per Share ttm -1.90
EPS Growth vs. Prev Qtr -27.78%
EPS Growth vs. Prev Year 20.69%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 12/06/22

CKPT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -659.07%
Profit Margin % -51,850.00%
Debt/Equity 0.00
Price/Sales 1,692.56
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.37
Interest Coverage -4.97
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar